Clinical Trials Logo

Clinical Trial Summary

Establishment of regular menstrual cycles is a key component of reproductive maturation and a recognized vital sign for health and well-being. Irregular menstrual cycles are especially common for the first 2-3 years after an adolescent's first menstrual period (i.e., menarche), which delays the identification and diagnosis of early reproductive disturbances such as polycystic ovary syndrome (PCOS). The purpose of this research study is to determine whether the ovary can serve as a reliable predictor of normal or abnormal development by following the trajectory of ovarian morphology in conjunction with menstrual cyclicity using 3D transabdominal ultrasound imaging in a prospective cohort study of adolescents. A secondary objective is to identify potential environmental factors such as diet and the gut microbiome which influence the trajectory towards normal or abnormal reproductive development.


Clinical Trial Description

Establishment of regular menstrual cycles is a key component of reproductive maturation and a recognized vital sign for health and well-being. Irregular menstrual cycles are especially common for the first 2-3 years after an adolescent's first menstrual period (i.e., menarche), which delays the identification and diagnosis of early reproductive perturbations and subsequent future disease risk. Therefore, the objectives of this study are to determine whether there are distinct aspects of ovarian morphology that predict the likelihood of regular menses or cycle irregularity at 2y post-menarche and to determine whether diet or lifestyle (such as quality of sleep) contribute to changes in the ovaries and period patterns. A group of up to 60 adolescents will be enrolled into a prospective longitudinal cohort study. Participants will attend four study visits to their location's respective clinical research center. Study visits will occur at four distinct time points post-menarche: 6-10 months, 11-13 months, 17-19 months, and 23-25 months. Prior to each of the study visits, participants will undergo one planned 24-hr dietary recall by a member of the research team and self-collect a stool sample. Participants will be asked to fast the night before the study visit. At each study visit, participants will undergo the following assessments: A 3D transabdominal ultrasound of the ovaries and uterus. A fasting blood sample, obtained via venipuncture. A series of anthropometric assessments, including: height, weight, waist and hip circumference, blood pressure, heart rate, and body fat percentage obtained using a bioimpedance scale. Tanner stage assessment, using a standardized self-report scoring scheme and by a trained member of the research team who is blinded to the results of the self-reported tanner stage. Acne scoring, using a standardized scoring scheme by a member of the research team. Hirsutism assessment, obtained by visually inspecting nine pre-defined regions of the body for terminal hair growth using a standardized scoring scheme by a trained member of the research team. Urine sample, self-collected by the participant after the transabdominal ultrasound. 24-hour dietary recall. Physical activity questionnaire. Two sleep questionnaires, including questions about sleep hygiene, sleep quality, and circadian rhythms. In between study visits, participants will maintain menstrual cycle diaries and medication diaries. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04424576
Study type Observational
Source Cornell University
Contact Heidi Vanden Brink, PhD
Phone 816-960-4186
Email hvandenbrink@cmh.edu
Status Recruiting
Phase
Start date January 31, 2020
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT01927432 - Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
Completed NCT00196391 - A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea Phase 2
Completed NCT00152282 - A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women Phase 2
Recruiting NCT00456274 - Baselines in Reproductive Disorders N/A
Terminated NCT00556400 - Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones Phase 1/Phase 2
Completed NCT00429494 - GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients Phase 2
Completed NCT04135729 - Mental Health in Fitness Instructors
Recruiting NCT06280807 - Observation of Environment and Reproductive-Endocrine Effects
Recruiting NCT03916978 - Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women Phase 2/Phase 3
Completed NCT00243607 - Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors N/A
Completed NCT00001275 - Ovarian Follicle Function in Patients With Primary Ovarian Failure N/A
Completed NCT04938622 - Bioenergetics of Exercise-Induced Menstrual Disturbances N/A
Not yet recruiting NCT02393482 - Psychological Impact of Amenorrhea in Women With Endometriosis Phase 4
Completed NCT01206153 - Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients Phase 4
Completed NCT02224976 - Effect of Intense Training on Ovarian Function and Bone Turnover N/A
Active, not recruiting NCT01785719 - Evaluation of Ovarian Morphology and Function in Overweight Women During Weight Loss N/A
Recruiting NCT00383656 - Pulsatile GnRH in Anovulatory Infertility Phase 2
Terminated NCT00881608 - Study to Evaluate Menses Induction in Women Administered Proellex Phase 1
Active, not recruiting NCT01103518 - Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation Phase 4
Withdrawn NCT00827151 - Bone Mass Accrual in Adolescent Athletes Phase 3